President Trump’s second presidential term marks a considerable shift in the political landscape, with significant implications for the health care and life sciences sector. With the issuance of new policies while rescinding prior polices set by previous administrations, coupled with recent Supreme Court rulings – it’s no surprise that this administration’s agenda is taking shape and setting the stage for a major transformation – and questions.

Health care litigation enforcement is a priority, with a focus on issues like the False Claims Act (FCA) and DEI. The future of Medicare Advantage remains uncertain as the new Centers of Medicare & Medicaid Services (CMS) nominees makes their way through the confirmation process. The U.S. Supreme Court’s rejection of Cheveron deference in Loper Bright Enterprises v. Raimondo paves way for new health care litigation as the new Administration gains force.

Health care and life sciences M&A remains a top concern. Several states have passed new laws that change how health care transactions need to be handled, including new regulatory filing requirements and approvals. These laws aim to monitor the impact of health care transactions on competition, quality, access, and cost of health care in the state. We provide a comprehensive overview of state-level health care material change transaction laws to consider when structuring your next transaction.

Artificial intelligence continues to dominate discussions and business trends. Many of the AI technologies that health care and life sciences companies adopt are largely untested from a legal perspective, creating significant regulatory gray areas. AI innovations also offer opportunities for competitive advantage through the strategic management of intellectual property rights, clinical trials, and medical devices.

Foley & Lardner’s 2025 Health Care & Life Sciences Top Trends publication unpacks these and other fast-moving developments to help your business capitalize on opportunities and navigate the potential pitfalls of an uncertain regulatory and litigation landscape.

Foley’s Health Care & Life Sciences Sector is comprised of 200+ attorneys with decades of collective in-house experience at health care providers and vendors, pharmaceutical and biotechnology firms, and key state and federal government agencies. Our attorneys have been deeply immersed in these industries, acquiring substantial technical and scientific knowledge through graduate degrees and ongoing training that enables us to provide forward-looking, practical solutions to our clients most pressing business challenges.

The 2025 Health Care & Life Sciences Top Trends Report includes the following articles.

• Government Enforcement and Health Care Litigation Under the Trump Administration’s Health Care Policies
• Medicare Payment Model Trends and Economic Drivers: Awaiting Direction from Trump Administration
• Private Equity and Health Care: Navigating Health Care Transaction Review Laws in 2025
• Health Care Data Deals & Transactions: Maximizing Value and Navigating Legal Risks
• Increased Scrutiny, New Regulations and Therapy Changes: Five Trends Revolutionizing Behavioral Health
• Post-Chevron Deference: A New Era for Legal Challenges to Health Care Regulations
• Top Trends in Antitrust Enforcement in Health Care: Private Equity, Pharmacy Benefit Managers (PBMs), Labor Protections, and more
• What’s Next for Telehealth and Digital Health Policy? Five Trends to Watch in 2025
• Artificial Intelligence (AI) Deployment Trends in Health Care and Life Sciences: How to Define and Execute Resilient Governance Frameworks
• Artificial Intelligence (AI) Patent Strategies for Medical Devices: IP Playbook for Emerging MedTech Companies
• Copyright Law Considerations for Artificial Intelligence (AI) in Pharmaceutical & Biopharmaceutical Industries
• Artificial Intelligence (AI)/Machine Learning (ML) in Medical Devices: FDA Continues to Develop its Regulatory Approach
• The Unique Role Artificial Intelligence (AI) Can Play in Pharmaceutical Clinical Trial Diversity

Complete the form to download the whitepaper now.